arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Adaptive Biotechnologies Corporation

ADPT Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$16.90
▼ -6.5% Today
as of Jun 7, 07:08 ET
Last 30 days +20.37% Apr 28 → Jun 05
$12.28 $13.84 $15.39 $16.95 $18.51 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$17.90
High
$18.29
Low
$16.68
Volume
$2M
Avg Vol
$2M
Mkt Cap
$2.4B
P/E (TTM)
Beta
52w High
$20.76
52w Low
$9.78
Div Yield
Shares Out
$160M

Overview

52-week range
$9.78
$21
65% of range
Avg surprise (last 2)
+23.7%
Avg reaction (last 2)
-2.5%
0% positive
Latest IV / EM
113%
EM ±15.7% · $18 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.35$-0.25$-0.14$-0.04$0.06 Actual $-0.33Actual $-0.35Actual $-0.33Actual $-0.31Actual $-0.22Actual $-0.20Est $-0.28Actual $-0.17Actual $0.06Actual $-0.13Est $-0.16 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-46M$-10M$26M$62M$99M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 5, 2026Mar/2026 $-0.13 $-0.16 +18.8% +35.0% -5.0% earnings
Tue Sep 30, 2025Sep 2025 $0.06 financials
Mon Jun 30, 2025Jun 2025 $-0.17 financials
Thu May 1, 2025Mar/2025 $-0.20 $-0.28 +28.6% 0.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.22 financials
Sun Jun 30, 2024Jun 2024 $-0.31 financials
Sun Mar 31, 2024Mar 2024 $-0.33 financials
Sat Sep 30, 2023Sep 2023 $-0.35 financials
Fri Jun 30, 2023Jun 2023 $-0.33 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$71M$94M$59M$52M$46M$43M
Cost of revenue$19M$18M$18M$17M$17M$19M
Gross profit
Operating income$-19M$10M$-25M$-30M$-33M$-47M
Net income$-20M$10M$-26M$-30M$-32M$-46M
EPS (diluted)$-0.13$0.06$-0.17$-0.20$-0.22$-0.31

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$78M$70M$55M$43M$51M$48M$38M$60M
Inventory$11M$10M$10M$8M$9M$8M$12M$13M
Total current assets$292M$300M$281M$262M$256M$284M$308M$352M
Total assets$506M$513M$491M$497M$511M$539M$559M$585M
Long-term debt$125M$127M$129M$130M$132M$132M$133M$132M
Total liabilities$282M$288M$286M$317M$321M$337M$335M$343M
Total equity$216M$219M$204M$180M$190M$203M$224M$242M

Implied volatility — last 90 days

108%110%113%115%118% Jun 07 — IV 113% · EM ±15.7%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.